News

Vietnam Investment Review on MSN23h
BioCity s SC0062 wins breakthrough status for kidney disease treatment
BioCity Biopharma ("BioCity") announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD) to ...
PharmiWeb1d
Aldosterone-Renin Screening Market to Reach USD 1.1 Billion by 2035, Growing at 6.8% CAGR
The aldosterone-renin screening market is forecasted to grow from USD 574.8 million in 2025 to USD 1,109.7 million by 2035, at a CAGR of 6.8% during the forecast period. The aldosterone-renin ...
Verywell Health1d
6 Supplements That Can Raise Your Blood Pressure
Some common dietary supplements can increase blood pressure, especially if you have high blood pressure or heart problems ...
Heart disease landscape changes: Fewer heart attacks, but more deaths from failure and arrhythmias
While heart disease has been the leading cause of death in the U.S. for over a century, the past 50 years have seen a ...
ahajournals.org3d
Critical Review of Prorenin and (Pro)renin Receptor Research | Hypertension - AHA/ASA Journals
The renin-angiotensin system (RAS) plays an important role in cardiovascular and renal physiology and disease, ... Plasma renin and kidney function were normal, but plasma aldosterone levels were ...
The American Journal of Managed Care6d
Lorundrostat Yields Promising Results for Treatment of Hypertension in Patients with CKD and Albuminuria
Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney ...
ahajournals.org6d
Biochemical Effects of Losartan, a Nonpeptide Angiotensin II Receptor Antagonist, on the Renin-Angiotensin-Aldosterone System in Hypertensive Patients - AHA/ASA Journals
Abstract We investigated the effects of angiotensin II (Ang II) type 1 receptor blockade with losartan on the renin-angiotensin-aldosterone system in hypertensive patients (supine diastolic blood ...